Amendment to Amended and Restated Executive Employment by and between the Company and Luke J. Albrecht, dated as of February 26, 2024
Exhibit 10.23
AMENDMENT TO AMENDED AND RESTATED
EXECUTIVE EMPLOYMENT AGREEMENT
This AMENDMENT TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) is entered into as of the 26th day of February, 2024 (the “Execution Date”), between LUKE J. ALBRECHT (“Executive”) and Syndax Pharmaceuticals, Inc. (the “Company”) and supplements the terms of that certain amended and restated executive employment agreement by and between the Parties, dated as of April 27, 2020 (the “Agreement”). Capitalized terms used and not otherwise defined herein shall have the meaning ascribed to such terms in the Agreement.
RECITALS
AGREEMENT
NOW, THEREFORE, in consideration of the mutual promises contained herein, the Company and Executive agree as follows:
* * * * *
IN WITNESS WHEREOF, the parties have executed this Amendment on the Execution Date written above.
|
|
|
|
|
|
|
|
| ||||||
Syndax Pharmaceuticals, Inc. |
|
| EXECUTIVE | |||||||||||
|
|
|
|
| ||||||||||
By: |
/s/ Michael A. Metzger |
| By: |
/s/ Luke J. Albrecht | ||||||||||
|
|
|
|
|
|
|
| |||||||
Name: | Michael A. Metzger |
|
| Name: | Luke J. Albrecht | |||||||||
Title: |
| Chief Executive Officer |
|
|
|
|
|
|
1.